Biotech Values

[zipjet]

OK so mL is now running at 44.8% of the US market of ~$2.3B, or ~$1.0B. So there is some room for greater mL sales in the US.

But the bigger target would be ROW sales or another $2.1B. Is NVS seeking EU approval or any other xUS approval?

ij